SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending following the release of positive Week 52 Phase 3 trial results, which investors are positioning as a strong best-in-class indicator for their skin drug, sonelokimab. The community is actively debating the potential for an upcoming acquisition and monitoring institutional accumulation, while some retail traders express frustration over recent price volatility and the timeline for further clinical data readouts.

Keel Infrastructure Corp. engages in building artificial intelligence focused data centers and energy assets. It focuses on infrastructure and energy required to support high-performance computing and artificial intelligence workloads. The company was founded on April 1, 2026 and is headquartered in New York, NY.

Keel Infrastructure Corp.

Keel Infrastructure Corp

Keel Infrastructure Corp is trending as investors bet on the company's pivot from crypto mining to high-demand AI and HPC data center infrastructure, fueled by recent FERC grid connectivity mandates and anticipation of upcoming lease contracts. The community is actively discussing the stock's upward momentum, potential Russell 3000 index inclusion, and the impact of institutional positioning on future price action.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals is attracting intense community interest as high trading volume and recent insider activity fuel speculation about potential acquisition interest or upcoming strategic catalysts. Investors are actively discussing the impact of new management's positioning, while closely watching key technical levels and patent developments that could signal a breakout for the stock.

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Definium Therapeutics Inc.

Definium Therapeutics is trending due to positive topline Phase 3 data for its depression treatment, triggering significant investor interest and ongoing debate regarding its potential for commercial success against established psychedelic peers. Community discussions center on the company's clinical trial catalysts, cash runway, and the binary nature of upcoming data readouts in the competitive mental health space.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is trending as investors aggressively bid up memory stocks, fueled by reports of structural storage shortages and AI-driven data center demand. The community is actively debating the sustainability of this parabolic run, with some traders highlighting the stock's record-setting RSI as a sign of an overheating market while others point to institutional re-rating as evidence of a sustained supercycle.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc. is trending as the market reacts to its latest acquisition of Cyberhawk, a critical infrastructure intelligence firm, alongside anticipation surrounding its upcoming inclusion in the Russell 2000 index. While the community is actively debating the company's aggressive acquisition-based growth strategy and the potential impact of its unified autonomous defense architecture, investors are closely monitoring the stock's consolidation patterns while waiting for further contract-based catalysts.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is experiencing significant selling pressure and heightened volatility, as investors weigh concerns over subscriber growth against management's capital allocation and potential M&A activity. The community remains deeply polarized, with bears aggressively betting on further downside following recent technical breaks, while bulls are scouting for value in what they consider an oversold market leader.

Roundhill ETF Trust - Roundhill Memory ETF

The Roundhill Memory ETF (DRAM) is trending as investors capitalize on the structural AI-driven demand for HBM and storage, despite broader market volatility and uncertainty surrounding major upcoming IPOs. Community sentiment remains overwhelmingly bullish, with many participants framing the current price action as a strategic entry point for a long-term re-rating of the memory sector beyond its traditional cyclical history.

MP Materials Corp. engages in the production and marketing of rare earth specialty materials. It operates through the following segments: Materials and Magnetics. The Materials segment focuses on the operation of Mountain Pass, which produces refined rare earth oxides and related products, as well as rare earth concentrate products. The Magnetics segment is involved in the operation of Independence Facility, where the company began production of magnetic precursor products. The company was founded by James Henry Litinsky and Michael Rosenthal in 2017 and is headquartered in Las Vegas, NV.

MP Materials Corporation

MP Materials is under intense focus as China implements new export controls and security reviews on critical minerals, prompting community debate over domestic supply chain independence and the effectiveness of existing government partnerships. Investors are closely monitoring how the company handles compliance and competitive pressures while weighing the broader geopolitical implications of restricted dual-use material access for the U.S. defense industrial base.

REGENXBIO, Inc. is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Its product candidates include the NAV Technology Platform, which consists of exclusive rights to novel adeno-associated viral vectors, and therapeutic programs such as RGX-314, RGX-202, RGX-121, RGX-111, RGX-181, and RGX-381. The company was founded by Kenneth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.

Regenxbio Inc

Regenxbio is seeing significant volatility following a surprise FDA clinical hold on its gene therapy programs, which triggered investor anxiety ahead of a looming PDUFA date for its Hunter syndrome therapy. While the community remains deeply divided between those citing the potential for an approval and those betting on a complete response letter (CRL) due to safety concerns, investors are actively analyzing how this regulatory setback impacts the long-term viability of the company's broader AAV vector pipeline.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Lifeway Foods Celebrates 40 Years and National Kefir Day with Coast-to-Coast Events and Lifeway Kefir Shop Pop-Up in SoHo

Lifeway Foods Celebrates 40 Years and National Kefir Day with Coast-to-Coast Events and Lifeway Kefir Shop Pop-Up in SoHo Lifeway Foods Celebrates 40 Years and National Kefir Day with Coast-to-Coast Events and Lifeway Kefir Shop Pop-Up in SoHo PR Newswire MORTON GROVE, Ill., June 15, 2026 An...

EDWARD SMOLYANSKY, KEY LWAY SHAREHOLDER: TERMINATION OF POISON PILL MARKS IMPORTANT INFLECTION POINT FOR LIFEWAY SHAREHOLDERS AS GOVERNANCE QUESTIONS MOUNT AHEAD OF THE ELECTION

EDWARD SMOLYANSKY, KEY LWAY SHAREHOLDER: TERMINATION OF POISON PILL MARKS IMPORTANT INFLECTION POINT FOR LIFEWAY SHAREHOLDERS AS GOVERNANCE QUESTIONS MOUNT AHEAD OF THE ELECTION EDWARD SMOLYANSKY, KEY LWAY SHAREHOLDER: TERMINATION OF POISON PILL MARKS IMPORTANT INFLECTION POINT FOR LIFEWAY...

Danone to sell Lifeway Foods stake

Lifeway Foods Announces Pricing of Secondary Underwritten Public Offering of Common Stock

Lifeway Foods Announces Pricing of Secondary Underwritten Public Offering of Common Stock Lifeway Foods Announces Pricing of Secondary Underwritten Public Offering of Common Stock PR Newswire MORTON...

Lifeway Foods Announces Record-Breaking Results for the First Quarter Ended March 31, 2026

Lifeway Foods Announces Record-Breaking Results for the First Quarter Ended March 31, 2026 Lifeway Foods Announces Record-Breaking Results for the First Quarter Ended March 31, 2026 PR Newswire...

Lifeway Foods, Inc. (NASDAQ:LWAY) Short Interest Update

Lifeway Foods, Inc. (NASDAQ:LWAY - Get Free Report) saw a large increase in short interest in the month of April. As of April 15th, there was short interest totaling 278,205 shares, an increase of...

Lifeway Foods (NASDAQ:LWAY) Stock Passes Above Two Hundred Day Moving Average   - Here's Why

Lifeway Foods (NASDAQ:LWAY) Shares Cross Above 200 Day Moving Average - What's Next...

Lifeway Foods Partners with Erewhon to Launch Tropical Lifeway Smoothie, Made with Organic Lifeway Kefir

Lifeway Foods Partners with Erewhon to Launch Tropical Lifeway Smoothie, Made with Organic Lifeway Kefir Lifeway Foods Partners with Erewhon to Launch Tropical Lifeway Smoothie, Made with Organic...

Lifeway Foods (NASDAQ:LWAY) Major Shareholder Sells $397,500.00 in Stock

Lifeway Foods, Inc. (NASDAQ:LWAY - Get Free Report) major shareholder Ludmila Smolyansky sold 15,000 shares of the stock in a transaction that occurred on Monday, April 20th. The shares were sold at...

Lifeway Foods (NASDAQ:LWAY) Stock Price Crosses Above Two Hundred Day Moving Average   - Time to Sell?

Lifeway Foods (NASDAQ:LWAY) Stock Price Crosses Above 200 Day Moving Average - Here's Why...

Lifeway Foods, Inc. engages in the manufacture of probiotic and nutritious foods. The firm's products include kefir, organic kefir, probiotic smoothie with collagen, muscle mates, probugs, and cheese. It distributes its products primarily through its direct sales force, brokers, and distributors. The company was founded by Michael Smolyansky and Ludmila Smolyansky in February 1986 and is headquartered in Morton Grove, IL.

Lifeway Foods, Inc.

Lifeway Foods Stock's Retail Followers Stay Bearish After Q4 Earnings Miss

Equity

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

LWAYLifeway Foods, Inc.

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest LWAY News